In vivo evaluation of tigemonam, a novel oral monobactam.

Tigemonam, a new monobactam with excellent activity against gram-negative bacteria, was evaluated for in vivo efficacy and absorption after oral administration to laboratory animals. Tigemonam is absorbed when administered orally to mice and dogs. In a variety of gram-negative systemic infections in...

ver descrição completa

Detalhes bibliográficos

Publicado no:	Antimicrob Agents Chemother
Principais autores:	Clark, J M, Olsen, S J, Weinberg, D S, Dalvi, M, Whitney, R R, Bonner, D P, Sykes, R B
Formato:	Artigo
Idioma:	Inglês
Publicado em:	American Society for Microbiology (ASM) 1987
Assuntos:	Research Article
Acesso em linha:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC174696/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/3551830/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.31.2.226
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!